1.Dealtry G.B., O’Farrell M.K., Fernandez N. The Th2 cytokine environment of the placenta. Int. Arch. Allergy. Immunol., 2000, v.123, p. 107-119.2.Malan Borel I., Gentile T., Angelucci J. et al. IgG asymmetric molecules with antipaternal activity isolated from sera and placenta of pregnant human. J. Rep. Immunol., 1991, v. 20, P. 129-140.3.Barrientos G., Fuchs D., Schröcksnadel K. et al. Low levels of serum asymmetric antibodies as a marker of threatened pregnancy. J. Rep. Immunol., 2009, v. 79, p. 201-210.4.Dechend R., Müller D.N., Wallukat G. et al. Activating auto-antibodies against the AT1 receptor in preeclampsia. Autoimmun. Rev., 2005, v. 4, p. 61-65.5.Hanly, J.G. Antiphospholipid syndrome: an overview. Can. Med. Assoc. J., 2003, v. 168, p. 1675-1682.6.Lutz H.U. Homeostatic roles of naturally occurring antibodies: an overview. J. Autoimmun., 2007, v. 29, p. 287-294.7.Бовин Н.В. Естественные антитела к гликанам. Биохимия, 2013, т.78, №7. с. 1008-1022.8.Gu J., Taniguchi N. Potential of N-glycan in cell adhesion and migration as either a positive or negative regulator. Cell. Adh. Migr., 2008, v. 2, p. 243-245.9.Kaufmann P., Black S., Huppertz B. Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol. Reprod., 2003, v. 69, p. 1-7.10.van de Bovenkamp F.S., Hafkenscheid L., Rispens T., Rombouts Y. The emerging importance of IgG Fab glycosylation in immunity. J. Immunol., 2016, v. 196, p. 1435-1441.11.Huflejt M.E., Vuskovic M., Vasiliu D. et al. Anticarbohydrate antibodies of normal sera: findings, surprises and challenges. Mol. Immunol., 2009, v. 46, p. 3037-3049.12.Vuskovic M., Xu H., Bovin N.V. et al. Processing and analysis of serum antibody binding signals from Printed Glycan Arrays for diagnostic and prognostic applications. Int.J. Bioinf. Res., 2011, v. 7, p. 402-426.13.McDonald J.H. Handbook of Biological Statistics. Sparky House Publishing, Baltimore, Maryland. 2014, p. 299.